ELV ELEVANCE HEALTH INC

2026Q1 · CUSIP 036752103 · Sector: Financials

Fading · Price holds, watch

Holders

1,457

Δ holders QoQ

-94

Breadth percentile

Top 99%

Whale holders

338

Δ whales

Inst. holding value

$56.8B

New positions

143

Closed positions

237

Price momentum (1Q)

+15.0%

Put / Call

24/25

Breadth history (34 quarters)

Past Lit Events & Aftermath 18 lit events

Period	Percentile	Next-1Q return	Next-2Q return
2025Q4	Top 12%	+15.0%	—
2025Q1	Top 2%	-22.4%	-17.2%
2024Q2	Top 5%	-24.9%	-27.4%
2023Q4	Top 2%	+7.2%	+6.7%
2023Q2	Top 19%	-0.4%	+10.1%
2022Q4	Top 2%	-6.3%	-4.4%
2022Q2	Top 6%	-0.0%	-0.5%
2022Q1	Top 2%	-1.0%	-3.2%
2021Q4	Top 2%	+4.2%	+7.8%
2021Q2	Top 14%	+16.5%	+18.6%
2021Q1	Top 6%	-4.1%	+11.7%
2020Q4	Top 6%	+36.4%	+30.8%
2020Q2	Top 5%	+18.0%	+3.2%
2019Q4	Top 4%	-7.1%	-5.7%
2019Q1	Top 1%	+4.3%	+7.0%
2018Q4	Top 4%	-14.3%	-11.8%
2018Q3	Top 16%	+9.0%	-2.7%
2018Q1	Top 16%	+15.4%	+21.6%

Show all 18 events

Options Sentiment

Put holders

QoQ: -2

Call holders

QoQ: -8

See methodology →

Fundamentals

PE (TTM)

16.9

EPS (TTM)

$22.59

EPS YoY

-4.2%

Revenue (TTM)

$201.1B

Revenue YoY

+6.3%

Net margin

2.5%

ROE

11.1%

Debt ratio

64.4%

FCF (TTM)

$6.3B

Dividend (TTM)

$6.86

Quarterly Revenue & EPS (4Y)

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-06-30 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.